CSPC Innovation Pharmaceutical Co Ltd SZSE:300765:
SAYS CO SUBMITS LISTING APPLICATION TO HONG KONG STOCK EXCHANGE
CSPC Innovation Submits Listing Application To Hong Kong Stock Exchange
Earlier from Cspc Innovation Pharmaceutical Co., Ltd. Class A
- CSPC Innovation Pharmaceutical: Revenue up 7.71% but net loss deepens; biopharma focus strengthened by Jushi stake buy
- CSPC Innovation Pharmaceutical Plans To Seek Hong Kong Listing
- CSPC Innovation Pharmaceutical: Revenue up, but net loss driven by R&D surge; biopharma growth and global deals highlight H1
- CSPC Innovation Pharmaceutical: Revenue fell and losses widened in Q1 2025 amid R&D surge and raw material price drops